Stephen Y. Chan, MD, PhD, ATSF examines the next generation of PAH therapies and the scientific breakthroughs redefining what's possible. Learn how basic, translational, and clinical research are converging to identify novel therapeutic targets, accelerate drug development, and shape the future of pulmonary hypertension care.